Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients

被引：81

作者：

Antonopoulos, S

Mikros, S

Mylonopoulou, M

Kokkoris, S ^{[1
]}

Giannoulis, G

机构：

[1] Tzanio Gen Hosp Piraeus, Prevent Care Unit, Athens, Greece

[2] Tzanio Gen Hosp Piraeus, Dept Internal Med 2, Athens, Greece

[3] Tzanio Gen Hosp Piraeus, Hepatol Unit, Athens, Greece

来源：

ATHEROSCLEROSIS | 2006年 / 184卷 / 01期

关键词：

rosuvastatin; fatty liver disease; steatosis; anticholesteremic agents;

D O I：

10.1016/j.atherosclerosis.2005.08.021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：233 / 234

页数：2

共 9 条

[1] Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease [J].

Donnelly, KL ;

Smith, CI ;

Schwarzenberg, SJ ;

Jessurun, J ;

Boldt, MD ;

Parks, EJ .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) :1343-1351

[2]

Hatzitolios Apostolos, 2004, Indian J Gastroenterol, V23, P131

[3] One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: A pilot study [J].

Huang, MA ;

Greenson, JK ;

Chao, C ;

Anderson, L ;

Peterman, D ;

Jacobson, J ;

Emick, D ;

Lok, AS ;

Conjeevaram, HS .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (05) :1072-1081

[4] Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis [J].

Kiyici, M ;

Gulten, M ;

Gurel, S ;

Nak, SG ;

Dolar, E ;

Savci, G ;

Adim, SB ;

Yerci, O ;

Memik, F .

CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (12) :713-718

[5] Treatment of nonalcoholic fatty liver disease [J].

Suthat Liangpunsakul ;

Naga Chalasani .

Current Treatment Options in Gastroenterology, 2003, 6 (6) :455-463

[6] New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments [J].

Lieber C.S. .

Current Gastroenterology Reports, 2004, 6 (1) :60-65

[7] Efficacy and safety of rosuvastatin in treatment of dyslipidemia [J].

McKenney, JM .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (10) :1033-1047

[8] Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis [J].

Medina, J ;

Fernández-Salazar, LI ;

García-Buey, L ;

Moreno-Otero, R .

DIABETES CARE, 2004, 27 (08) :2057-2066

[9] Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. (vol 7, pg 430, 2004) [J].

Stender, S ;

Schuster, H ;

Barter, P ;

Watkins, C ;

Kallend, D .

DIABETES OBESITY & METABOLISM, 2005, 7 (04) :460-460

← 1 →